Logan Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Logan Capital Management's NVO Position: Q1 2026 in Review
Logan Capital Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 18,511 shares — an estimated $877K sold.
Logan Capital Management first reported a position in NVO in Q1 2021 and held it in 20 quarters. The position peaked at $4.22M in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Logan Capital Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Logan Capital Management sold 18,511 Novo Nordisk shares in Q1 2026, an estimated $877K.
- Logan Capital Management first reported a position in Novo Nordisk in Q1 2021 and held it in 20 quarters.
- Logan Capital Management's Novo Nordisk position peaked at $4.22M in Q2 2024.
- 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.